Interferon-α treatment of hepatitis C virus-associated mixed cryoglobulinemia

Journal of Hepatology

Volumn 27, Issue 1, 1997, Pages 63-71

  Polzien, Frank ^a   Schott, Peter ^a   Mihm, Sabine ^a   Ramadori, Giuliano ^a   Heinz, Hartmann ^a  

^a Department of Medicine   (Germany)

Author keywords

Hepatitis C genotypes; Hepatitis C virus; Interferon ; Mixed cryoglobulinemia

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA INTERFERON; AMINOTRANSFERASE; BILIRUBIN; COMPLEMENT; CRYOGLOBULIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; PROTEIN; RECOMBINANT ALPHA2A INTERFERON; RHEUMATOID FACTOR; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0030790681     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80281-4     Document Type: Article

References (35)

1. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Tharaval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology. 19:1994;841-848.
2. Ferri C, Longombardo G, La Civita L, Greco F, Lombardini F, Cecchetti R, et al. Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J Intern Med. 236:1994;31-36.
3. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 21:1995;613-619.
4. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 57:1974;775-788.
5. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis. 162:1990;569-570.
6. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol. 9:1991;621-624.
7. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 327:1992;1490-1495.
8. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 117:1992;573-577.
9. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med. 88:1995;115-126.
10. Marcellin P, Descamps V, Martinot-Peignoux M, Larzul D, Xu L, Boyer N, et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology. 104:1993;272-277.
11. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 328:1993;465-470.
12. Levey JM, Bjornsson B, Banner B, Kuhns M, Malhotra R, Whitman N, et al. Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature. Medicine. 73:1994;53-67.
13. Pingel S, Hartmann H, Ramadori G. Essential mixed cryoglobulinemia (EMC) in a case of chronic hepatitis C. Successful treatment with interferon alpha. Z Gastroenterol. 32:1994;584-588.
14. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR. Cryoglobulinemia presenting after liver transplantation. Gastroenterology. 110:1996;265-267.
15. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 330:1994;751-756.
16. Johnson RJ, Gretch DR, Couser WG, Alpers CE, Wilson J, Chung M, et al. Hepatitis C virus-associated glomerulonephritis Effect of α-interferon therapy. Kidney Int. 46:1994;1700-1704.
17. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 106:1994;1291-1300.
18. Hartmann H, Schott P, Polzien F, Mihm S, Uy A, Kaboth U, et al. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestation, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol. 33:1995;643-650.
19. Willems M, Sheng L, Roskams T, Ramdani B, Doutrelepont JM, Nevens F, et al. Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis with or without a cryoglobulinemia-related syndrome. J Med Virol. 44:1994;266-271.
20. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia M, Andre C, Voisin MC, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C serotypes. Ann Intern Med. 122:1995;169-173.
21. Sinico RA, Ribero ML, Fornasieri A, Renoldi P, Zhou J, Fasalo M, et al. Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia. Q J Med. 88:1995;805-810.
22. Conjeevaram HS, Everhart JE, Hoofnagle JH. Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C. Hepatology. 22:1995;1326-1329.
23. Chemello L, Bonetti P, Cavalleto L, Talato F, Donadon V, Casarin P, et al. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology. 22:1995;700-706.
24. Schubothe H, Westerhausen M. Nachweismethoden und Vorkommen von Kryoglobulinen. Dtsch Med Wochenschr. 35:1970;1786-1788.
25. Okamoto H, Sugiyama Y, Okada K, Kurai Y, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 73:1992;673-679.
26. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primer for specific detection. J Gen Virol. 74:1993;2385-2390.
27. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Duscheiko G, et al. Sequence variability in the 5′-non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol. 74:1993;661-668.
28. Wong VS, Egner W, Elsey T, Brown D, Alexander GJM. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol. 104:1996;25-31.
29. Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood. 81:1993;1132-1136.
30. Durand JM, Cretel E, Kaplanski G, Lefevre P, Retornaz F, Soubeyrand J. Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection. Clin Rheumatol. 13:1994;123-125.
31. Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchinlo V, Iacobelli AR, et al. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood. 84:1994;3336-3343.
32. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med. 83:1987;726-730.
33. Casato M, Lagana B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with interferon-α for type II essential mixed cryoglobulinemia. Blood. 78:1991;3142-3147.
34. Glück T, Dürk H, Kötter I, Zimmermann C, Saal JG. Kryoglobulinämie bei chronischer Hepatitis C. Besserung durch alfa-Interferon unabhängig von der Viruselimination. Med Klin. 90:1995;674-680.
35. Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripodi MF, et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol. 28:1996;1-9.